Chronic haloperidol treatment decreases preproenkephalin mRNA in the anterior pituitary: a study by solution-hybridization-RNase protection assay

Neurosci Lett. 1996 Dec 27;221(1):66-8. doi: 10.1016/s0304-3940(96)13274-2.

Abstract

By solution-hybridization-RNase protection assay, the preproenkephalin (PPek) mRNA in the anterior pituitary (AL) of male rats was found to decrease by 42% after 3 weeks haloperidol treatment. It is concluded that dopamine may stimulate the AL enkephalinergic system at the level of gene expression.

MeSH terms

  • Animals
  • Dopamine Antagonists / pharmacology*
  • Electrophoresis, Polyacrylamide Gel
  • Enkephalins / analysis
  • Enkephalins / genetics*
  • Gene Expression / drug effects
  • Haloperidol / pharmacology*
  • Male
  • Nucleic Acid Hybridization
  • Pituitary Gland / chemistry
  • Pituitary Gland / drug effects*
  • Pituitary Gland / physiology
  • Protein Precursors / analysis
  • Protein Precursors / genetics*
  • RNA, Messenger / analysis
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Ribonucleases
  • Time Factors

Substances

  • Dopamine Antagonists
  • Enkephalins
  • Protein Precursors
  • RNA, Messenger
  • preproenkephalin
  • Ribonucleases
  • Haloperidol